At meeting held on 28 September 2015
Mangalam Drugs and Organics announced that the Board of Directors of the Company at its Meeting held on 28 September 2015, inter alia, transacted the following business:Allotted 26,50,000 convertible share warrants at Rs. 65/- (including premium of Rs. 55/-) to JB Pharma LLP, Promoter group on preferential basis in accordance with the Chapter VII of SEBI (ICDR) Regulation 2009. In terms of their issue the warrants are convertible into equity shares within the period of 18 months from the date of allotment.
Powered by Capital Market - Live News